ArticleAmerican journal of translational research2021

Combination of ultra-low dose rituximab and low dose tacrolimus versus tacrolimus alone in the treatment of non-responsive idiopathic membranous nephropathy: a Chinese retrospective cohort study.

Fan Zhu et al.PubMed ↗Full text ↗

No numbers read from the abstract.